Search Results 971-980 of 11201 for Antifungal Resistance
Platinum-resistant/refractory disease, defined as disease progression within 6 months following the last administered dose of platinum therapy (resistant) ...
About this study. The purpose of this study is to assess the safety, pharmacokinetics and tolerability, describe the dose-limiting toxicities (DLTs), ...
A "Registry" is a list of basic information about people who have a certain disease or condition in common. These immune deficiency diseases are thought to be ...
Subject has a known active bacterial, viral, fungal ... fungal infection of nail beds, minor upper ... Subject receiving treatment with breast cancer resistance ...
Multi-drug resistant bacterial or fungal chronic infections. Emergent/urgent ... Pure Pulmonary Resistance (Rp) patients. Eligibility last updated 11/4 ...
Have active, uncontrolled, systemic bacterial, viral, or fungal infection that requires treatment or have serious ongoing intercurrent illness that is not ...
Mayo Clinic study finds 1 in 8 adults carries hidden genetic risk — and reveals what · Mayo Clinic researchers identify molecule linked to treatment-resistant ...
... resistant relapsing multiple sclerosis (MS). ... fungal-free survival at Day 90 (±7 days). The ... fungal-free survival at Day 90 (±7 days). Phase II ...
... resistance to prior EGFR tyrosine kinase inhibitors. Profiling Of Lung Cancer For Identification Of Treatment Targets And Strategies Jacksonville, FL. The ...
Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS Using the LIPOSORBER® LA-15 System. Rochester, Minn., Jacksonville, Fla. The purpose ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.